Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and alzheimer’s dementia

HIGHLIGHTS

  • who: Lisa Y. Xiong from the Sciences Program, Sunnybrook Research Institute, Toronto, Canada Department of Pharmacology and Toxicology, University of Toronto, Room have published the Article: Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia, in the Journal: (JOURNAL)
  • what: The aim of this longitudinal study was to compare cognitive performance over time between users and non-users of an LTRA in a relatively larger sample of people with normal cognition, MCI, or AD dementia. The approach was conservative and intended to avoid the overestimation of possible . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?